Home › EU patent office revokes Celgene Revlimid patent; appeal planned
 

Keywords :   


EU patent office revokes Celgene Revlimid patent; appeal planned

2015-05-07 20:02:35| Biotech - Topix.net

Celgene Corp on Thursday said the European Patent Office revoked a key patent on the company's flagship multiple myeloma drug Revlimid, a move that could shave a year or two from the medicine's exclusivity in Europe. REUTERS: Celgene Corp on Thursday said the European Patent Office revoked a key patent on the company's flagship multiple myeloma drug Revlimid, a move that could shave a year or two from the medicine's exclusivity in Europe.

Tags: office planned patent appeal

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
04.10Should you tip even if the service wasn't worth it?
04.10Hurricane Kirk Graphics
04.10Hurricane Kirk Forecast Discussion Number 22
04.10Tropical Storm Leslie Forecast Discussion Number 10
04.10Hurricane Kirk Wind Speed Probabilities Number 22
04.10Hurricane Kirk Public Advisory Number 22
04.10Summary for Hurricane Kirk (AT2/AL122024)
04.10Tropical Storm Leslie Public Advisory Number 10
More »